Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society|December 24, 2010
Pseudomembranous colitis complicating ulcerative colitisHideto Kawaratani, Tatsuhiro Tsujimoto, Masahisa Toyohara, et al.
World Journal of Gastroenterology|October 22, 2008
Pneumatosis cystoides intestinalis following alpha-glucosidase inhibitor treatment: a case report and review of the literatureTatsuhiro Tsujimoto, Erika Shioyama, Kei Moriya, et al.
Internal Medicine (Tokyo, Japan)|March 10, 2015
Development of nodular regenerative hyperplasia (NRH) with portal hypertension following the administration of oxaliplatin for the recurrence of colon cancerHiroaki Takaya, Hideto Kawaratani, Keisuke Nakanishi, et al.
Internal Medicine (Tokyo, Japan)|September 15, 2005
Intrahepatic cholangiocarcinoma associated with central calcification and arterio-portal shuntMitsuteru Kitade, Hitoshi Yoshiji, Junichi Yamao, et al.
World Journal of Gastroenterology|November 16, 2006
Interferon augments the anti-fibrotic activity of an angiotensin-converting enzyme inhibitor in patients with refractory chronic hepatitis CHitoshi Yoshiji, Ryuichi Noguchi, Hideyuki Kojima, et al.
Alcoholism, Clinical and Experimental Research|December 31, 2005
Decreased activity of plasma ADAMTS13 may contribute to the development of liver disturbance and multiorgan failure in patients with alcoholic hepatitisMasahito Uemura, Tomomi Matsuyama, Masatoshi Ishikawa, et al.
Oncology Reports|August 30, 2011
Combination of branched-chain amino acids and angiotensin-converting enzyme inhibitor suppresses the cumulative recurrence of hepatocellular carcinoma: a randomized control trialHitoshi Yoshiji, Ryuichi Noguchi, Yasuhide Ikenaka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 2, 2012
ADAMTS13 activity may predict the cumulative survival of patients with liver cirrhosis in comparison with the Child-Turcotte-Pugh score and the Model for End-Stage Liver Disease scoreHiroaki Takaya, Masahito Uemura, Yoshihiro Fujimura, et al.
Molecular Medicine Reports|November 18, 2011
Combination of branched-chain amino acid and angiotensin-converting enzyme inhibitor improves liver fibrosis progression in patients with cirrhosisHitoshi Yoshiji, Ryuichi Noguchi, Yasuhide Ikenaka, et al.
Parasitology International|March 27, 2007
Cystic echinococcosis in immigrant from Peru: first case treated with percutaneous treatment in JapanHiroshi Sakaguchi, Toshihiro Tanaka, Nagaaki Marugami, et al.
Pageof 2